Jun 2026 (Q2 FY26) — Aug 6, 2026
McEwen Inc. Q2 FY26 — Operational Shortfalls Offset by Strategic Project Advancement
Read the full callMcEwen (MUX) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
McEwen earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 59.2 | +26.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 13.0 | +20.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 9.6 | +216.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$16.05 −1.17% · −$0.19
Performance −24.6% 1Y
1Y: $21.28 on 17 Oct 2025 → $16.05. High $29.05 (28 Jan 2026), low $15.6 (14 Oct 2026).
- Previous close
- $16.24
- 52-week range
- $15.6 – $29.05
- One year
- −28.73%
Overview
- Symbol
- MUX
- Sector
- Materials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
McEwen earnings calls (MUX)
Financials
What the filings say
Net profit, year on year: +216% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 52 | 34 | 36 | 47 | 51 | 65 | 74 | 59 |
| Expenses | 14 | 15 | 18 | 16 | 16 | — | -10 | 12 |
| Operating profit | -0 | -15 | -8 | -3 | -8 | 22 | 41 | 8 |
| Operating margin | −0.2% | −43.4% | −21.4% | −7.2% | −16.7% | 34.2% | 55.7% | 13.0% |
| Other income | -1 | 7 | 0 | 5 | 7 | -8 | -8 | -2 |
| Profit before tax | -1 | -7 | -7 | 2 | -2 | 14 | 33 | 6 |
| Tax rate | −64.3% | −15.0% | 14.7% | −57.6% | 73.3% | −170.4% | −0.5% | −65.9% |
| Net profit | -2 | -8 | -6 | 3 | -0 | 38 | — | 10 |
| EPS ($ per share) | -0.04 | -0.16 | -0.12 | 0.06 | -0.01 | 0.70 | 0.56 | 0.16 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1,457 | 1,531 | 1,549 | 1,615 | 1,644 | 1,768 | 1,805 | 1,822 |
| Reserves | -971 | -1,031 | -1,184 | -1,240 | -1,321 | -1,266 | -1,310 | -1,275 |
| Total liabilities | 131 | 132 | 135 | 135 | 172 | 155 | 170 | 274 |
| Fixed assets | 115 | 108 | 49 | — | — | — | — | — |
| Investments | — | — | — | — | — | 2 | 2 | 21 |
| Total assets | 617 | 631 | 500 | 525 | 529 | 657 | 665 | 820 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0 | -40 | -28 | -20 | -57 | -40 | 29 | 7 |
| Cash from investing | -69 | -14 | -12 | -25 | -24 | -100 | -58 | -48 |
| Cash from financing | 60 | 70 | 18 | 81 | 65 | 172 | 19 | 79 |
| Net cash flow | -7 | 16 | -22 | 36 | -17 | -16 | -10 | 38 |
| Capital expenditure | -62 | -30 | -13 | -35 | -24 | -26 | -43 | -45 |
| Free cash flow | -62 | -69 | -41 | -55 | -81 | -66 | -14 | -38 |
Insider filings
37 filings between Nov 10, 2025 and Jul 27, 2026.
Open market
decisions to buy or sellPurchases
$18.4K
1 purchase by 1 insider
Sales
$59.4K
1 sale by 1 insider
Compensation
not trading decisions- 1
- Award — granted as compensation
- 34
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Brissenden Richard W. | — | $59.4K | Jun 29, 2026 |
| Kaszas Stephen Douglas | $18.4K | — | Jun 5, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 27, 2026 | McEwen Robert Ross Chairman and CEO | Award | 1,526,785 | — |
| Jun 29, 2026 | Brissenden Richard W. Director | Option exercise | 8,333 | $59.2K |
| Jun 29, 2026 | Brissenden Richard W. Director | Sale | 3,275 | $59.4K |
| Jun 29, 2026 | Ball Ian J Director | Option exercise | 160 | — |
| Jun 29, 2026 | Ing Perry Chief Financial Officer | Option exercise | 686 | — |
| Jun 29, 2026 | Ing Perry Chief Financial Officer | Option exercise | 337 | — |
| Jun 29, 2026 | Ing Perry Chief Financial Officer | Option exercise | 91 | — |
| Jun 29, 2026 | Shaver William M Chief Operating Officer | Option exercise | 11,740 | — |
| Jun 29, 2026 | Shaver William M Chief Operating Officer | Option exercise | 5,700 | — |
| Jun 29, 2026 | Shaver William M Chief Operating Officer | Option exercise | 1,480 | — |
| Jun 28, 2026 | Chan Jeffrey VP - Finance | Option exercise | 588 | — |
| Jun 28, 2026 | Chan Jeffrey VP - Finance | Option exercise | 248 | — |
| Jun 28, 2026 | Ing Perry Chief Financial Officer | Option exercise | 116 | — |
| Jun 28, 2026 | Shaver William M Chief Operating Officer | Option exercise | 2,100 | — |
| Jun 28, 2026 | Shaver William M Chief Operating Officer | Option exercise | 866 | — |
| Jun 28, 2026 | Ing Perry Chief Financial Officer | Option exercise | 270 | — |
| Jun 5, 2026 | Kaszas Stephen Douglas Director | Purchase | 1,000 | $18.4K |
| Dec 20, 2025 | Chan Jeffrey VP - Finance | Option exercise | 248 | — |
| Dec 20, 2025 | Shaver William M Chief Operating Officer | Option exercise | 867 | — |
| Dec 20, 2025 | Ing Perry Chief Financial Officer | Option exercise | 867 | — |
| Dec 20, 2025 | Ing Perry Chief Financial Officer | Option exercise | 372 | — |
| Dec 20, 2025 | Ball Ian J Director | Option exercise | 160 | — |
| Dec 20, 2025 | Ing Perry Chief Financial Officer | Option exercise | 2,203 | — |
| Dec 20, 2025 | Ing Perry Chief Financial Officer | Option exercise | 1,083 | — |
| Dec 20, 2025 | Shaver William M Chief Operating Officer | Option exercise | 11,740 | — |
| Dec 20, 2025 | Shaver William M Chief Operating Officer | Option exercise | 5,700 | — |
| Dec 20, 2025 | Shaver William M Chief Operating Officer | Option exercise | 2,100 | — |
| Nov 10, 2025 | Spears Stephan Michael VP Corporate Development | Option exercise | 232 | — |
| Nov 10, 2025 | Spears Stephan Michael VP Corporate Development | Option exercise | 558 | — |
| Nov 10, 2025 | Chan Jeffrey VP - Finance | Option exercise | 248 | — |
| Nov 10, 2025 | Diges Carmen L General Counsel/Corp Sec | Option exercise | 672 | — |
| Nov 10, 2025 | Diges Carmen L General Counsel/Corp Sec | Option exercise | 276 | — |
| Nov 10, 2025 | Chan Jeffrey VP - Finance | Option exercise | 588 | — |
| Nov 10, 2025 | Ing Perry Chief Financial Officer | Option exercise | 867 | — |
| Nov 10, 2025 | Ing Perry Chief Financial Officer | Option exercise | 372 | — |
| Nov 10, 2025 | Shaver William M Chief Operating Officer | Option exercise | 2,100 | — |
| Nov 10, 2025 | Shaver William M Chief Operating Officer | Option exercise | 867 | — |
| Sep 22, 2025 | Chan Jeffrey VP - Finance | Option exercise | 13,333 | $94.7K |
| Sep 22, 2025 | Chan Jeffrey VP - Finance | Sale | 13,333 | $198.5K |
| Sep 22, 2025 | Brissenden Richard W. Director | Sale | 4,775 | $71.1K |
| Sep 22, 2025 | Brissenden Richard W. Director | Option exercise | 8,334 | $59.2K |
| Sep 22, 2025 | Brissenden Richard W. Director | Sale | 6,428 | $95.7K |
| Sep 22, 2025 | Brissenden Richard W. Director | Option exercise | 7,500 | $9.4K |
| Sep 19, 2025 | Spears Stephan Michael VP Corporate Development | Sale | 12,600 | $180.8K |
| Sep 19, 2025 | Spears Stephan Michael VP Corporate Development | Option exercise | 12,600 | $15.8K |
| Sep 19, 2025 | Diges Carmen L General Counsel/Corp Sec | Sale | 21,000 | $301.2K |
| Sep 19, 2025 | Diges Carmen L General Counsel/Corp Sec | Option exercise | 21,000 | $26.3K |
| Sep 19, 2025 | McEwen Robert Ross Chairman and CEO | Sale | 50,000 | $717.3K |
| Sep 19, 2025 | McEwen Robert Ross Chairman and CEO | Option exercise | 50,000 | $62.5K |
| Aug 12, 2025 | Ball Ian J Director | Sale | 2,656 | $27.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for McEwen Inc.
Free account. Everything above stays public.
Write why you follow McEwen Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading